Your browser is no longer supported. Please, upgrade your browser.
Settings
CTXR [NASD]
Citius Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.38 Insider Own9.14% Shs Outstand96.00M Perf Week7.84%
Market Cap358.24M Forward P/E8.87 EPS next Y0.31 Insider Trans0.00% Shs Float68.11M Perf Month45.50%
Income-21.10M PEG- EPS next Q-0.05 Inst Own13.30% Short Float23.22% Perf Quarter32.85%
Sales- P/S- EPS this Y42.00% Inst Trans110.91% Short Ratio2.59 Perf Half Y129.17%
Book/sh1.30 P/B2.12 EPS next Y203.30% ROA-33.40% Target Price- Perf Year217.63%
Cash/sh0.80 P/C3.45 EPS next 5Y- ROE-39.60% 52W Range0.78 - 2.90 Perf YTD169.61%
Dividend- P/FCF- EPS past 5Y20.00% ROI- 52W High7.41% Beta1.58
Dividend %- Quick Ratio35.20 Sales past 5Y- Gross Margin- 52W Low299.36% ATR0.18
Employees10 Current Ratio35.20 Sales Q/Q- Oper. Margin- RSI (14)78.80 Volatility7.75% 7.14%
OptionableNo Debt/Eq0.00 EPS Q/Q66.70% Profit Margin- Rel Volume6.98 Prev Close2.75
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume6.10M Price3.12
Recom2.00 SMA2032.52% SMA5047.97% SMA200111.65% Volume23,987,196 Change13.27%
Jun-15-21 09:20AM  
Jun-08-21 02:11PM  
09:00AM  
Jun-07-21 09:00AM  
Jun-03-21 08:18AM  
May-25-21 02:52PM  
May-18-21 09:29AM  
May-17-21 12:30PM  
May-13-21 07:30AM  
May-11-21 04:30PM  
May-04-21 09:15AM  
Apr-29-21 09:37AM  
Apr-22-21 04:30PM  
Apr-19-21 08:53AM  
Mar-23-21 09:00AM  
Mar-04-21 10:11AM  
Feb-19-21 04:47PM  
11:34AM  
Feb-17-21 12:28AM  
Feb-16-21 09:15AM  
Feb-08-21 08:35AM  
Feb-04-21 10:16AM  
Feb-02-21 08:00AM  
Jan-28-21 08:35AM  
Jan-27-21 01:00PM  
Jan-25-21 07:00AM  
Jan-06-21 09:00AM  
Dec-18-20 12:57AM  
Dec-15-20 09:40AM  
Dec-09-20 09:40AM  
Dec-08-20 09:15AM  
Dec-03-20 03:30PM  
Nov-30-20 09:15AM  
Nov-10-20 09:30AM  
Nov-09-20 09:30AM  
Oct-27-20 09:00AM  
Oct-13-20 07:30AM  
Oct-07-20 07:00AM  
Sep-30-20 09:45AM  
Sep-29-20 10:17AM  
Sep-22-20 08:15AM  
Sep-15-20 10:17AM  
Sep-08-20 10:00AM  
Sep-01-20 04:34PM  
Aug-27-20 09:00AM  
Aug-26-20 10:00AM  
Aug-13-20 09:45AM  
Aug-10-20 03:18PM  
Aug-05-20 05:32PM  
09:00AM  
Aug-04-20 08:17AM  
Jul-22-20 10:30AM  
Jul-20-20 02:00PM  
Jul-14-20 08:47AM  
Jul-13-20 08:15AM  
Jun-30-20 08:54AM  
Jun-29-20 09:07AM  
08:35AM  
Jun-26-20 09:00AM  
Jun-23-20 08:49AM  
Jun-22-20 01:17PM  
Jun-02-20 09:30AM  
May-26-20 08:15AM  
May-18-20 02:30PM  
May-15-20 06:49AM  
May-14-20 09:00AM  
May-13-20 08:15AM  
May-12-20 08:00AM  
Apr-27-20 09:30AM  
Apr-01-20 08:07AM  
Mar-26-20 09:06AM  
Mar-18-20 09:46AM  
Mar-16-20 06:22AM  
Mar-03-20 04:45PM  
Feb-26-20 08:00AM  
Feb-25-20 08:00AM  
Feb-10-20 08:28AM  
Feb-04-20 08:00AM  
Feb-03-20 08:00AM  
Jan-27-20 08:00AM  
Dec-19-19 08:00AM  
Dec-04-19 08:00AM  
Nov-08-19 08:00AM  
Oct-24-19 08:00AM  
Oct-15-19 08:00AM  
08:00AM  
08:00AM  
Oct-07-19 08:30AM  
Oct-03-19 07:00AM  
Sep-28-19 07:52AM  
Sep-27-19 11:28AM  
Sep-25-19 07:00AM  
Sep-04-19 06:55AM  
Aug-29-19 08:00AM  
Jul-30-19 08:00AM  
Jul-24-19 03:38PM  
May-24-19 08:53AM  
May-13-19 08:47AM  
May-01-19 08:00AM  
Apr-30-19 09:45AM  
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, prescription, and mesenchymal stem cell therapy products. The company is developing Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter, which is in Phase III clinical trials; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.